G.T.Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 8.93 M
- Company Age 29 Year, 8 Months
- Last Filing with ROC 31 Mar 2006
- Open Charges ₹ 10.88 Cr
About G.T.Pharma
G.T.Pharma Private Limited (GPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 June 1995 and has a history of 29 years and eight months. Its registered office is in Jaipur, Rajasthan.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2006. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 8.93 M.
The company currently has active open charges totaling ₹10.88 Cr.
Madhu Bhartia, Bimla Bhartia, and Sanjay Bhartia serve as directors at the Company.
Company Details
- Location Jaipur, Rajasthan
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232RJ1995PTC010190
- Company No.
010190
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jun 1995
- Date of AGM
30 Sep 2006
- Date of Balance Sheet
31 Mar 2006
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at G.T.Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Bhartia  | Managing Director | 09-Jun-1995 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madhu Bhartia | Director | 10-May-2006 | Current |
| Bimla Bhartia | Director | 27-Dec-2006 | Current |
Financial Performance of G.T.Pharma.
Enhance accessibility to G.T.Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of G.T.Pharma?
Unlock access to G.T.Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
G T Biopharma Private LimitedSanjay Bhartia is a mutual person
Charges (Loans)
₹10.88 Cr
₹0
Charges Breakdown by Lending Institutions
- Indian Overseas Bank : 9.93 Cr
- Bank Of India : 0.95 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 May 2008 | Indian Overseas Bank | ₹9.93 Cr | Open |
| 13 Jun 2006 | Bank Of India | ₹9.50 M | Open |
How Many Employees Work at G.T.Pharma?
Unlock and access historical data on people associated with G.T.Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of G.T.Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped G.T.Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.